Jiangsu Yahong Meditech Co (SHSE:688176) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Jiangsu Yahong Meditech Co EBITDA Margin % Related Terms
Jiangsu Yahong Meditech Co EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688176 vs ZTS, UTHR: EBITDA Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Jiangsu Yahong Meditech Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jiangsu Yahong Meditech Co EBITDA Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Jiangsu Yahong Meditech Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Jiangsu Yahong Meditech Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jiangsu Yahong Meditech Co (SHSE:688176) has a EBITDA Margin % of -157.22% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Jiangsu Yahong Meditech Co and its competitors. According to the industry distribution chart, Jiangsu Yahong Meditech Co ranks #893 out of 952 companies in the Drug Manufacturers industry, placing it in the top 93.8%.
Is Jiangsu Yahong Meditech Co's EBITDA Margin % too high?
Jiangsu Yahong Meditech Co's current EBITDA Margin % is -157.22%. Based on the distribution chart, Jiangsu Yahong Meditech Co ranks #893 out of 952 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Jiangsu Yahong Meditech Co has a GF Score™ of 43/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Jiangsu Yahong Meditech Co's EBITDA Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Jiangsu Yahong Meditech Co ranks #893 out of 952 companies for EBITDA Margin %. This places Jiangsu Yahong Meditech Co in the lower half of its industry. The industry median EBITDA Margin % is 12.47. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.47, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Jiangsu Yahong Meditech Co and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jiangsu Yahong Meditech Co's current EBITDA Margin % is -157.22%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangsu Yahong Meditech Co stock overvalued right now?
Based on GuruFocus' analysis, Jiangsu Yahong Meditech Co (SHSE:688176) is currently considered Possible Value Trap. The stock's GF Value™ is ¥17.91, compared to a current price of ¥9.92 — trading 44.6% below its estimated fair value. The current EBITDA Margin % is -157.22%. Jiangsu Yahong Meditech Co's overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Jiangsu Yahong Meditech Co (SHSE:688176), the current EBITDA Margin % is -157.22% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jiangsu Yahong Meditech Co (SHSE:688176) Overvalued in 2026?
Based on GuruFocus' analysis, Jiangsu Yahong Meditech Co stock appears to be undervalued.
The current stock price of ¥9.92 is trading 44.6% below its estimated GF Value™ of ¥17.91.
GuruFocus considers Jiangsu Yahong Meditech Co to be Possible Value Trap.
Key valuation signals for SHSE:688176:
EBITDA Margin %: -157.22%
GF Value™: ¥17.91 vs. price of ¥9.92 (44.6% below fair value)
No single metric tells the full story. See the SHSE:688176 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jiangsu Yahong Meditech Co Ltd is a pharmaceutical company integrating research and development, production and commercialization in the field of focused treatment, providing the integration of diagnosis and treatment for Chinese and global patients Solutions.
43GF Score
Get the complete analysis for SHSE:688176
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688176 has been successfully added to your 
